15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English EASL2019 FRI-138 HBVcore-与HBV聚合酶特异性CD8 + T细 ...
查看: 655|回复: 1
go

EASL2019 FRI-138 HBVcore-与HBV聚合酶特异性CD8 + T细胞的区别在于 [复制链接]

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

1
发表于 2019-4-8 15:00 |只看该作者 |倒序浏览 |打印
FRI-138
HBVcore- versus HBVpolymerase-specific CD8+ T cells differ in
chronically HBV-infected patients
Kathrin Heim1,2, Anita Schuch1,2, Elahe Salimi Alizei1,3,
Janine Kemming1,2, Hendrik Luxenburger1,
Christoph Neumann-Haefelin1, Maike Hofmann1, Robert Thimme1.
1Department of Medicine II, University Hospital Freiburg, Freiburg,
Germany; 2Faculty of Biology, University of Freiburg, Freiburg, Germany;
3Faculty of Chemistry and Pharmacy, University of Freiburg, Freiburg,
Germany
Email: [email protected]
Background and aims: Chronic Hepatitis B virus (HBV) infection is
characterized by the presence of impaired HBV-specific CD8+ T-cell
responses. T-cell exhaustion induced by persistent antigen stimulation
is considered a major mechanismunderlying HBV-specific CD8+
T-cell failure. However, due to low frequencies of detectable HBVspecific
CD8+ T-cell populations in chronically HBV-infected patients,
it is currently unknown whether HBV-specific CD8+ T cells targeting
different epitopes are similarly impaired and share molecular profiles
indicative of T-cell exhaustion.
Method: To enhance detection of HBV-specific CD8+ T-cell responses,
we performed pMHCI tetramer-based enrichment of circulating
CD8+ T cells specific for HBV core- and polymerase-derived epitopes
in 88 cHBV patients with low viral loads. Subsequently, phenotypic
and functional in-depth analyses were performed using multicolor
flow cytometry. Patients were pre-selected for autologous viral
sequences that matched the targeted epitopes by the analyzed
HBV-specific CD8+ T cells.
Results: We were able to detect HBV-specific CD8+ T cells ex vivo in
the majority (> 80%) of tested patients. Specifically, core- and
polymerase-, but not envelope-specific CD8+ T cells were frequently
found. Interestingly, these HBV-specific CD8+ T cells exhibited a
predominantly less differentiated memory-like phenotype characterized
by CD127+PD1+, showed lowTOX expression and lacked signs
of terminal exhaustion, possibly reflecting weak ongoing cognateantigen recognition. However, within the HBV-specific population,
we found significant differences in phenotype and function between
core- and polymerase-specific CD8+ T cells. Indeed, more corespecific
CD8+ T cells displayed the CD127+PD1+ memory-like phenotype
compared to polymerase-specific CD8+ T cells. This observation
is in line with the advanced differentiation of polymerase-specific
CD8+ T cells towards more severe T-cell exhaustion marked by higher
CD38, KLRG1 and Eomes expression accompanied by low T-bet levels
and down-regulation of CD127. Polymerase-specific CD8+ T cells also
exhibited a reduced expansion capacity compared to core-specific
CD8+ T cells that was linked to dysregulated TCF1/BCL2 and high
Eomes expression in polymerase-specific CD8+ T cells. These differences
were only detectable in HBV-specific CD8+ T cells obtained
from chronically infected patients and not from patients who
resolved HBV.
Conclusion: Overall, the results of our study show different
molecular mechanisms underlying impaired T-cell responses with
respect to the targeted HBV antigens core versus polymerase in cHBV
infection. This may have potential implications for the design of
immunotherapeutic approaches in HBV cure.

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

2
发表于 2019-4-8 15:00 |只看该作者
FRI-138
HBVcore-与HBV聚合酶特异性CD8 + T细胞的区别在于
慢性HBV感染的患者
Kathrin Heim1,2,Anita Schuch1,2,Elahe Salimi Alizei1,3,
Janine Kemming1,2,Hendrik Luxenburger1,
Christoph Neumann-Haefelin1,Maike Hofmann1,Robert Thimme1。
弗赖堡弗莱堡大学医院1医学系,
德国; 2德国弗赖堡弗莱堡大学生物学院;
弗赖堡弗莱堡大学化学与药学院,
德国
电子邮件:[email protected]
背景和目的:慢性乙型肝炎病毒(HBV)感染
特征在于存在受损的HBV特异性CD8 + T细胞
响应。持续抗原刺激诱导T细胞衰竭
被认为是HBV特异性CD8 +的主要机制
T细胞衰竭。但是,由于HBV特异性可检测的低频率
慢性HBV感染患者的CD8 + T细胞群,
目前尚不清楚HBV特异性CD8 + T细胞是否靶向
不同的表位同样受损并且共享分子谱
指示T细胞衰竭。
方法:增强HBV特异性CD8 + T细胞反应的检测,
我们进行了基于pMHCI四聚体的循环富集
CD8 + T细胞特异于HBV核心和聚合酶衍生的表位
88例cHBV患者病毒载量低。随后,表型
使用多色进行功能性深入分析
流式细胞术。患者预先选择自体病毒
通过分析匹配目标表位的序列
HBV特异性CD8 + T细胞。
结果:我们能够体外检测HBV特异性CD8 + T细胞
大多数(> 80%)受试患者。具体来说,核心和
聚合酶 - 但不是包膜特异性CD8 + T细胞经常发生
找到。有趣的是,这些HBV特异性CD8 + T细胞表现出一种
主要是较少分化的记忆样表型
通过CD127 + PD1 +,显示低TOX表达并且缺乏迹象
终末衰竭,可能反映弱持续的同源抗原识别。但是,在HBV特定人群中,
我们发现两者之间的表型和功能存在显着差异
核心和聚合酶特异性CD8 + T细胞。实际上,更多的核心特定
CD8 + T细胞显示CD127 + PD1 +记忆样表型
与聚合酶特异性CD8 + T细胞相比。这个观察
符合聚合酶特异性的高级分化
CD8 + T细胞朝向更严重的T细胞衰竭标志着更高
CD38,KLRG1和Eomes表达伴有低T-bet水平
和CD127的下调。聚合酶特异性CD8 + T细胞也
与核心特异性相比,扩增能力降低
CD8 + T细胞与失调的TCF1 / BCL2相关且高
Eomes在聚合酶特异性CD8 + T细胞中表达。这些差异
仅在获得的HBV特异性CD8 + T细胞中可检测到
来自慢性感染的患者,而不是来自患者
解决了HBV。
结论:总的来说,我们的研究结果显示出不同的结果
T细胞反应受损的分子机制
关于cHBV中靶向HBV抗原核心与聚合酶的关系
感染。这可能会对设计产生潜在影响
HBV治疗中的免疫治疗方法。
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-11-16 03:16 , Processed in 0.012755 second(s), 11 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.